Clinical Trial Update: Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a conjugate pneumococcal vaccine in patients with Ataxia Telangiectasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Drugs mentioned

• Conjugate Pneumococcal Vaccine (pneumococcal conjugate vaccine)

Snippet

Sponsor: Institute of Child Health | Conditions: Ataxia Telangiectasia (AT) | Phase 3 | Status: COMPLETED